Showing results (61-70 of 225) with videos related to
Sort By:
Pageof 23
Nature Medicine|March 31, 2000
Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy childrenP R Krause, D M KlinmanBiologicals : Journal of the International Association of Biological Standardization|May 8, 2000
Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNAA Sierra-Honigmann, P R KrauseJournal of Virology|July 1, 1993
Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNAH Moriuchi, M Moriuchi, S E Straus, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donorsA Yachie, G Tosato, S E Straus, et al.Virology|September 18, 1999
Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivationR A LeBlanc, L Pesnicak, M Godleski, et al.Journal of Virology|May 1, 1993
Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promotersH Moriuchi, M Moriuchi, S E Straus, et al.Annals of Internal Medicine|January 1, 1993
NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and managementS E Straus, J I Cohen, G Tosato, et al.Molecular and Cellular Biology|October 1, 1994
The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoterJ L Meier, X Luo, M Sawadogo, et al.Virology|April 1, 1994
Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNAM Moriuchi, H Moriuchi, S E Straus, et al.The Journal of Infectious Diseases|August 7, 1999
The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in miceR A LeBlanc, L Pesnicak, M Godleski, et al.Pageof 23